Management of Extrinsic Compressive Malignancy at the Gastroesophageal Junction
For extrinsic compression causing narrowing at the gastroesophageal junction (GEJ), proceed immediately with endoscopy and contrast-enhanced CT or FDG-PET-CT of the thorax, abdomen, and pelvis to identify the compressing malignancy, followed by endoscopic ultrasound (EUS) for T and N staging 1.
Diagnostic Approach
The diagnostic workup must be aggressive and systematic:
- Endoscopy is mandatory to visualize the compression, assess the degree of luminal narrowing, and obtain tissue diagnosis if possible 1
- Cross-sectional imaging with contrast-enhanced CT or FDG-PET-CT is essential to identify the source of extrinsic compression (most commonly pancreatic cancer, lymphoma, or metastatic disease) 1, 2
- EUS should be performed for accurate T and N staging of the compressing lesion 1
- For locally advanced tumors (T3/T4) crossing the diaphragm, add laparoscopy to the staging workup 1
Key Clinical Red Flags
Research shows that extrinsic compression with the following features dramatically increases malignancy likelihood 2:
- Gastrointestinal symptoms (60% vs 22% abnormal CT findings)
- Weight loss (50% vs 16% abnormal CT findings)
- Hypoalbuminemia
- Posterior gastric body compression (signals pancreatic cancer)
Pancreatic cancer is the most common malignancy causing extrinsic GEJ compression 2.
Management Strategy
If Curative Intent is Possible
Do NOT place a self-expanding metal stent (SEMS) in patients who are potential candidates for resection or chemoradiation without multidisciplinary review 3. This is critical because stenting in the neoadjuvant setting causes:
- High stent migration rates
- Increased morbidity and mortality
- Lower R0 resection rates 3
Instead, for malnourished patients requiring nutritional support:
- Use enteral feeding tubes (nasogastric or percutaneous route) rather than stenting 3
- Be aware that percutaneous endoscopic gastrostomy (PEG) carries risk of abdominal wall tumor seeding and may complicate future gastric conduit formation 3
- Nutritional support should follow ESPEN guidelines and be provided before curative-intent therapy 1
If Palliative Management is Required
When the patient is not a surgical candidate or has unresectable disease:
For esophageal/GEJ obstruction:
- Use fully covered SEMS (FCSEMS) or partially covered SEMS (PCSEMS), NOT uncovered SEMS 3
- Use larger diameter stents (20-23 mm) when crossing the GEJ to prevent migration 3
- Consider stent-anchoring methods (endoscopic suturing or over-the-scope clips) to reduce migration risk 3
- Alternative: Brachytherapy as sole therapy or combined with stenting 3
Critical caveat: Avoid stenting in patients undergoing curative-intent therapy as it worsens prognosis 1.
For Gastric Outlet Obstruction from Extrinsic Compression
If the compression extends to cause gastric outlet obstruction:
Surgical gastrojejunostomy (laparoscopic preferred) for patients with:
- Life expectancy >2 months
- Good functional status
- Surgical fitness 3
Enteral stenting for patients with:
- Life expectancy <2 months
- Poor surgical candidates 3
Do not use enteral stents in patients with multiple luminal obstructions or severely impaired gastric motility 3.
Multidisciplinary Decision-Making
All treatment decisions must be made in a multidisciplinary setting including oncologists, surgeons, and endoscopists, considering 3:
- Characteristics of the obstruction
- Patient's prognosis and functional status
- Expected subsequent therapies
- Patient expectations and quality of life goals
Common Pitfalls to Avoid
- Never routinely stent potentially resectable disease without multidisciplinary review 3
- Avoid small-diameter stents (<20 mm) at the GEJ due to increased migration risk 3
- Do not use uncovered SEMS due to tumor ingrowth and need for re-intervention 3
- Recognize that gastroesophageal reflux occurs in 70-100% of esophageal SEMS placements 3
- Document TNM staging according to latest AJCC/UICC guidelines 1